SoftBank rumored to invest in PharmEasy parent company API Holdings Image by: TechStory In a fresh investment round, API is looking for a valuation of at least $5.6 billion, according to one of the sources, who want to remain anonymous because the details are confidential as of now. SoftBank may invest between $150 million and $200 million in the healthtech unicorn. The API Holdings also seeks to approach more possible investors for the fundraising round, in the following 12 to 18 months the company plans to go public. However, there are ongoing discussions, and SoftBank may possibly opt-out against any investment. Moreover, representatives for API Holdings and SoftBank refused to comment on the matter.